Nuria Climent

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Fingolimod increases cellular resistance to HIV-1 infection and limits viral reservoir size in peripheral CD4+ T-cells.

Fingolimod increases cellular resistance to HIV-1 infection and limits viral reservoir size in peripheral CD4+ T-cells.

Journal: PLoS pathogens

Published: December 19, 2025

Changes in Cellular Senescence Biomarkers Across Individuals at Different Stages of HIV Infection Before and After a Year on Antiretroviral Therapy.

Changes in Cellular Senescence Biomarkers Across Individuals at Different Stages of HIV Infection Before and After a Year on Antiretroviral Therapy.

Journal: The Journal of infectious diseases

Published: December 12, 2025

Cellular senescence meets infection: highlights from the 10th annual International Cell Senescence Association (ICSA) conference, Rome 2025.

Cellular senescence meets infection: highlights from the 10th annual International Cell Senescence Association (ICSA) conference, Rome 2025.

Journal: Aging

Published: November 19, 2025

Immune reconstitution in very advanced HIV patients treated with dolutegravir vs. darunavir-based triple antiretroviral therapy: the Advanz-4 randomized clinical trial.

Immune reconstitution in very advanced HIV patients treated with dolutegravir vs. darunavir-based triple antiretroviral therapy: the Advanz-4 randomized clinical trial.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: August 16, 2025

HIV-Tat upregulates the expression of senescence biomarkers in CD4+ T-cells.

HIV-Tat upregulates the expression of senescence biomarkers in CD4+ T-cells.

Journal: Frontiers in immunology

Published: January 30, 2025

Intracellular HIV-1 Tat regulator induces epigenetic changes in the DNA methylation landscape.

Intracellular HIV-1 Tat regulator induces epigenetic changes in the DNA methylation landscape.

Journal: Frontiers in immunology

Published: November 22, 2024

Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging.

Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging.

Journal: Pharmaceutics

Published: February 18, 2023

Pharmacokinetics, the Immunological Impact, and the Effect on HIV Ex-Vivo Infectivity of Maraviroc, Raltegravir, and Lopinavir in Men Who Have Sex with Men Using Postexposure Prophylaxis.

Pharmacokinetics, the Immunological Impact, and the Effect on HIV Ex-Vivo Infectivity of Maraviroc, Raltegravir, and Lopinavir in Men Who Have Sex with Men Using Postexposure Prophylaxis.

Journal: AIDS research and human retroviruses

Published: November 23, 2022

Immunological and virological findings in a patient with exceptional post-treatment control: a case report.

Immunological and virological findings in a patient with exceptional post-treatment control: a case report.

Journal: The lancet. HIV

Published: September 14, 2022

Highly Efficient Autologous HIV-1 Isolation by Coculturing Macrophage With Enriched CD4+ T Cells From HIV-1 Patients.

Highly Efficient Autologous HIV-1 Isolation by Coculturing Macrophage With Enriched CD4+ T Cells From HIV-1 Patients.

Journal: Frontiers in virology (Lausanne, Switzerland)

Published: August 15, 2022

Natural killer cells act as an extrinsic barrier for in vivo reprogramming.

Natural killer cells act as an extrinsic barrier for in vivo reprogramming.

Journal: Development (Cambridge, England)

Published: November 15, 2021

Effect of Intranodally Administered Dendritic Cell-Based HIV Vaccine in Combination With Pegylated Interferon α-2a on Viral Control Following ART Discontinuation: A Phase 2A Randomized Clinical Trial.

Effect of Intranodally Administered Dendritic Cell-Based HIV Vaccine in Combination With Pegylated Interferon α-2a on Viral Control Following ART Discontinuation: A Phase 2A Randomized Clinical Trial.

Journal: Frontiers in immunology

Published: August 30, 2021

Showing 1-12 of 34

Last Updated: 09/26/2026